Advertisement
Research Article| Volume 32, ISSUE 3, 106952, March 2023

Outcomes following thrombectomy for acute large vessel occlusion beyond 24 hours or with unknown time of onset

      Abstract

      Background

      Endovascular thrombectomy (EVT) is recommended in medically eligible patients with large vessel occlusions (LVO) within 24 hours of symptom onset. While there is evidence that EVT ≥24h after last known well (LKW) is associated with favorable outcomes in patients who meet DAWN/DEFUSE-3 criteria, it is unknown if more liberal criteria can be applied.

      Methods

      A single center, prospective observational cohort of consecutive adult stroke patients was queried for symptomatic occlusions of the internal carotid (ICA) or proximal middle cerebral (M1) arteries (October 2019-January 2022), with a National Institutes of Health Stroke Scale (NIHSS) ≥6, pre-stroke modified Rankin Scale (mRS) 0-2, and Alberta Stroke Program Early Computed Tomography Scale score 3-10. These inclusion criteria were extrapolated from recently published data indicating a benefit with EVT with more liberal patient selection. Patients who underwent EVT ≥24h after LKW were compared against those treated medically. The primary outcome was a good functional outcome (90-day mRS 0-2), which was evaluated using multivariable logistic regression.

      Results

      Of the 27 included patients, the median age was 65y (IQR 49-76) with a median NIHSS of 15 (IQR 8-26), and 17 (63.0%) underwent EVT (median LKW-to-puncture 35.5h (IQR 26.9-65.8h). The primary outcome was no different with EVT in unadjusted regression (OR 1.17, 95%CI 0.17-8.09), and there remained no association across all multivariable models tested. Age, pre-stroke disability, and M1 occlusions were non-significantly associated with the primary outcome (p>0.05). There was a non-significant trend indicating a favorable shift in 90-day mRS with EVT (proportional OR 2.04, 95%CI 0.44-9.48).

      Conclusions

      Using more liberal inclusion criteria for EVT in the ultra-extended window, there was no statistically significant difference in the rate of good functional outcome with EVT. Larger studies are called upon to evaluate outcomes when more liberal criteria are used to assess thrombectomy eligibility.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Powers W.J.
        • Rabinstein A.A.
        • Ackerson T.
        • Adeoye O.M.
        • Bambakidis N.C.
        • Becker K.
        • Biller J.
        • Brown M.
        • Demaerschalk B.M.
        • Hoh B.
        • et al.
        Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2019; 50: e344-e418
        • Jovin T.G.
        • Nogueira R.G.
        • Lansberg M.G.
        • Demchuk A.M.
        • Martins S.O.
        • Mocco J.
        • Ribo M.
        • Jadhav A.P.
        • Ortega-Gutierrez S.
        • Hill M.D.
        • et al.
        Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
        Lancet. 2022; 399: 249-258
        • Albers G.W.
        • Lansberg M.G.
        • Brown S.
        • Jadhav A.P.
        • Haussen D.C.
        • Martins S.O.
        • Rebello L.C.
        • Demchuk A.M.
        • Goyal M.
        • Ribo M.
        • et al.
        Assessment of optimal patient selection for endovascular thrombectomy beyond 6 hours after symptom onset: a pooled analysis of the AURORA database.
        JAMA Neurol. 2021; 78: 1064-1071
        • Meinel T.R.
        • Kaesmacher J.
        • Mordasini P.
        • Mosimann P.J.
        • Jung S.
        • Arnold M.
        • Heldner M.R.
        • Michel P.
        • Hajdu S.D.
        • Ribo M.
        • et al.
        Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry.
        Ther Adv Neurol Disord. 2019; 121756286419835708
        • Goyal M.
        • Menon B.K.
        • van Zwam W.H.
        • Dippel D.W.J.
        • Mitchell P.J.
        • Demchuk A.M.
        • Dávalos A.
        • Majoie C.B.L.M.
        • van der Lugt A.
        • de Miquel M.A.
        • et al.
        Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
        Lancet. 2016; 387: 1723-1731
        • Pagiola I.
        • Chassin O.
        • Gallas S.
        • Riviere M.S.
        • Legris N.
        • Mihalea C.
        • Caroff J.
        • Ikka L.
        • Chalumeau V.
        • de Aguiar G.B.
        • et al.
        Extending the stroke treatment window beyond DAWN in patients with very slow progressor type collaterals: how far can we go?.
        J Cerebrovasc Endovasc Neurosurg. 2021; 23: 354-358
        • Fuse Y.
        • Tajima H.
        • Kimura K.
        • Nakamura S.
        • Kurimoto F.
        • Watanabe K.
        A case of mechanical thrombectomy for acute occlusion of the left internal carotid artery later than 24 hours after onset.
        J Neuroendovasc Therapy. 2021; ([Internet]advpub. Available from:)https://doi.org/10.5797/jnet.cr.2020-0079
        • Siegler J.E.
        • Messé S.R.
        • Sucharew H.
        • Kasner S.E.
        • Mehta T.
        • Arora N.
        • Starosciak A.K.
        • La Rosa F.D.L.R.
        • Barnhill N.R.
        • Mistry A.M.
        • et al.
        Thrombectomy in DAWN- and DEFUSE-3-ineligible patients: a subgroup analysis from the BEST prospective cohort study [Internet].
        Neurosurgery. 2020; 86 (Available from:): E156-E163https://doi.org/10.1093/neuros/nyz485
        • Manning N.W.
        • Wenderoth J.
        • Alsahli K.
        • Cordato D.
        • Cappelen-Smith C.
        • McDougall A.
        • Zagami A.S.
        • Cheung A.
        Endovascular thrombectomy >24-hr from stroke symptom onset [Internet].
        Front Neurol. 2018; 9 (Available from:)https://doi.org/10.3389/fneur.2018.00501
        • Desai S.M.
        • Haussen D.C.
        • Aghaebrahim A.
        • Al-Bayati A.R.
        • Santos R.
        • Nogueira R.G.
        • Jovin T.G.
        • Jadhav A.P.
        Thrombectomy 24 hours after stroke: beyond DAWN.
        J Neurointerv Surg. 2018; 10: 1039-1042
        • Kim B.J.
        • Menon B.K.
        • Kim J.Y.
        • Shin D.-W.
        • Baik S.H.
        • Jung C.
        • Han M.-K.
        • Demchuk A.
        • Bae H.-J.
        Endovascular treatment after stroke due to large vessel occlusion for patients presenting very late from time last known well.
        JAMA Neurol. 2020; ([Internet]Available from:)https://doi.org/10.1001/jamaneurol.2020.2804
        • de Havenon A.
        • Castonguay A.
        • Nogueira R.
        • Nguyen T.N.
        • English J.
        • Satti S.R.
        • Veznedaroglu E.
        • Saver J.L.
        • Mocco J.
        • Khatri P.
        • et al.
        Prestroke disability and outcome after thrombectomy for emergent anterior circulation large vessel occlusion stroke.
        Neurology. 2021; 97: e1914-e1919
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Siegler J.E.
        • Heslin M.E.
        • Thau L.
        • Smith A.
        Falling stroke rates during COVID-19 pandemic at a Comprehensive Stroke Center: Cover title: Falling stroke rates during COVID-19.
        J Stroke Cerebrovasc Dis. 2020; ([Internet] Available from:)
        • Wolpert S.M.
        • Bruckmann H.
        • Greenlee R.
        • Wechsler L.
        • Pessin M.S.
        • del Zoppo G.J.
        Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
        AJNR Am J Neuroradiol. 1993; 14: 3-13
        • del Zoppo G.J.
        • Poeck K.
        • Pessin M.S.
        • Wolpert S.M.
        • Furlan A.J.
        • Ferbert A.
        • Alberts M.J.
        • Zivin J.A.
        • Wechsler L.
        • Busse O.
        Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.
        Ann Neurol. 1992; 32: 78-86
        • Wahlgren N.
        • Ahmed N.
        • Dávalos A.
        • Ford G.A.
        • Grond M.
        • Hacke W.
        • Hennerici M.G.
        • Kaste M.
        • Kuelkens S.
        • Larrue V.
        • et al.
        Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.
        Lancet. 2007; 369: 275-282
        • Campbell B.C.V.
        • Ma H.
        • Ringleb P.A.
        • Parsons M.W.
        • Churilov L.
        • Bendszus M.
        • Levi C.R.
        • Hsu C.
        • Kleinig T.J.
        • Fatar M.
        • et al.
        Extending thrombolysis to 4\textperiodcentered 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
        Lancet. 2019; 394: 139-147
        • Yoshimura S.
        • Sakai N.
        • Yamagami H.
        • Uchida K.
        • Beppu M.
        • Toyoda K.
        • Matsumaru Y.
        • Matsumoto Y.
        • Kimura K.
        • Takeuchi M.
        • et al.
        Endovascular therapy for acute stroke with a large ischemic region.
        N Engl J Med. 2022; 386: 1303-1313
        • Albers G.W.
        • Marks M.P.
        • Kemp S.
        • Christensen S.
        • Tsai J.P.
        • Ortega-Gutierrez S.
        • McTaggart R.A.
        • Torbey M.T.
        • Kim-Tenser M.
        • Leslie-Mazwi T.
        • et al.
        Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.
        N Engl J Med. 2018; 378: 708-718
        • Nogueira R.G.
        • Jadhav A.P.
        • Haussen D.C.
        • Bonafe A.
        • Budzik R.F.
        • Bhuva P.
        • Yavagal D.R.
        • Ribo M.
        • Cognard C.
        • Hanel R.A.
        • et al.
        Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct.
        N Engl J Med. 2018; 378: 11-21
        • Nguyen T.N.
        • Abdalkader M.
        • Nagel S.
        • Qureshi M.M.
        • Ribo M.
        • Caparros F.
        • Haussen D.C.
        • Mohammaden M.H.
        • Sheth S.A.
        • Ortega-Gutierrez S.
        • et al.
        Noncontrast computed tomography vs computed tomography perfusion or magnetic resonance imaging selection in late presentation of stroke with large-vessel occlusion.
        JAMA Neurol. 2022; 79: 22-31
        • Ospel J.M.
        • Menon B.K.
        • Demchuk A.M.
        • Almekhlafi M.A.
        • Kashani N.
        • Mayank A.
        • Fainardi E.
        • Rubiera M.
        • Khaw A.
        • Shankar J.J.
        • et al.
        Clinical course of acute ischemic stroke due to medium vessel occlusion with and without intravenous Alteplase treatment.
        Stroke. 2020; 51: 3232-3240
        • Sarraj A.
        • Hassan A.E.
        • Abraham M.G.
        • Cardona Portela P.
        • Manning N.W.
        • Cordato D.
        • Kleinig T.J.
        • Goyal N.
        • Blackburn S.
        • McCullough-Hicks M.E.
        • et al.
        Abstract 36: endovascular thrombectomy beyond 24 hours from last known well: a pooled multicenter international cohort.
        Stroke. 2022; 53: A36
        • Meyer L.
        • Bechstein M.
        • Bester M.
        • Hanning U.
        • Brekenfeld C.
        • Flottmann F.
        • Kniep H.
        • van Horn N.
        • Deb-Chatterji M.
        • Thomalla G.
        • et al.
        Thrombectomy in extensive stroke may not be beneficial and is associated with increased risk for hemorrhage.
        Stroke. 2021; 52: 3109-3117
        • Liu X.
        • Dai Q.
        • Ye R.
        • Zi W.
        • Liu Y.
        • Wang H.
        • Zhu W.
        • Ma M.
        • Yin Q.
        • Li M.
        • et al.
        Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
        Lancet Neurol. 2020; 19: 115-122
        • Langezaal L.C.
        • van der Hoeven E.J.
        • Mont'Alverne FJ.
        Endovascular Therapy for stroke due to basilar-artery occlusion [Internet].
        J Emerg Med. 2021; 61: 116https://doi.org/10.1016/j.jemermed.2021.06.003
        • Rocha M.
        • Desai S.M.
        • Jadhav A.P.
        • Jovin T.G.
        Prevalence and temporal distribution of fast and slow progressors of infarct growth in large vessel occlusion stroke [Internet].
        Stroke. 2019; 50: 2238-2240https://doi.org/10.1161/strokeaha.118.024035
        • Siegler J.E.
        • Messé S.R.
        • Sucharew H.
        • Kasner S.E.
        • Mehta T.
        • Arora N.
        • Starosciak A.K.
        • De Los Rios La Rosa F.
        • Barnhill N.R.
        • Mistry A.M.
        • et al.
        Noncontrast CT versus perfusion-based core estimation in large vessel occlusion: the blood pressure after endovascular stroke therapy study.
        J Neuroimaging. 2020; 30: 219-226